F3 Logic, LLC Blueprint Medicines Corp Transaction History

F3 Logic, LLC

  • $475 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019
SELL
$72.9 - $101.41 $988,159 - $1.37 Million
-13,555 Closed
0 $0
Q2 2019

Aug 02, 2019
SELL
$73.54 - $97.8 $367,700 - $489,000
-5,000 Reduced 26.95%
13,555 $1.28 Million
Q1 2019

May 06, 2019
BUY
$48.7 - $86.6 $903,628 - $1.61 Million
18,555 New
18,555 $1.49 Million

Others Institutions Holding BPMC

# of Institutions
313
Shares Held
60.6M
Call Options Held
634K
Put Options Held
691K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.59B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track F3 Logic, LLC Portfolio

Follow F3 Logic, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

News

Stay updated on F3 Logic, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email